AdvisorShares Pure US Cannabis ETF MSOS
Set alert
4.20 USD +0.26 +6.60%
At close · Nov 2
4.26 +0.06 +1.43%
After hours · Nov 2, 7:59 PM ET
3.98 Day range 4.33
2.96 52-week range 7.25
- YTD
- -11.02%
- 1 year
- -6.46%
- Open
- 4.00
- Prev close
- 3.94
- Mkt cap
- 511.72M
- Vol
- 10.74M
- Avg vol
- 4.74M
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.98
- High
- 4.33
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.35
- 200-d avg
- 7.29
5D chart
Signals (86)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:50 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:05 PM | 11 hours ago |
| RSI: Overbought | Nov 2, 1:10 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 12:50 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 12:25 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 12:15 PM | 13 hours ago |
| RSI: Overbought | Nov 2, 11:40 AM | 14 hours ago |
| RSI: Overbought | Nov 2, 11:30 AM | 14 hours ago |
| MACD: Sell Signal | Nov 2, 11:25 AM | 14 hours ago |
| RSI: Overbought | Nov 2, 10:05 AM | 15 hours ago |
| RSI: Overbought | Oct 30, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:15 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:25 PM | 3 days ago |
| RSI: Oversold | Oct 30, 1:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:15 PM | 3 days ago |
Newest 20 of 86.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 5.35
- 200-day average
- 7.29
About AdvisorShares Pure US Cannabis ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
News
- Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
- AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) Shares Gap Down – Here’s What Happened
- MSOS: Pause On Cannabis Rescheduling - And Why Trulieve Is A Sneaky Pick
- 'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment
- Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD
- Virginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win.
- MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks
- The Easiest Way to Bet on US Cannabis Is This One ETF
- Trulieve Makes History As First US Cannabis Stock On NYSE
- 'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment
Your note
Sign in to keep a note on MSOS — it syncs with the Stock Master app.